Delay in resumption of the activity of tetracycline-regulatable promoter following removal of tetracycline analogues

Gene Therapy

Volumn 4, Issue 9, 1997, Pages 993-997

  A Mohammadi, S ^a   Alvarez Vallina, L ^a   Ashworth, L J ^a,b   Hawkins, R E ^a,b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

Author keywords

Anhydrotetracycline; Doxycycline; Minocycline; Oxytetracycline; Tetracycline; tTA responsive promoter

Indexed keywords

ANHYDROTETRACYCLINE; DOXYCYCLINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MINOCYCLINE; OXYTETRACYCLINE; PLASMID VECTOR; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GENE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE REPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION; TRANSGENE;

EID: 0030867445     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300491     Document Type: Article

References (33)

1. Schmidt W et al. Cancer vaccines: the interleukin 2 dosage effect. Proc Natl Acad Sci USA 1995; 92: 4711-4714.
2. Stevenson FK et al. Idiotypic DNA vaccines against B-cell lymphoma. Immunol Rev 1995; 145: 211-228.
3. Dranoff G et al Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993; 90: 3539-3543.
4. Yarranton GT. Inducible vectors for expression in mammalian cells. Curr Opin Biotechnol 1992; 3: 506-511.
5. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
6. Shockett PE, Schatz DG. Diverse strategies for tetracycline-regulated inducible gene expression. Proc Natl Acad Sci USA 1996; 93: 5173-5176.
7. Furth PA et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 1994; 91: 9302-9306.
8. Passman RS, Fishman GI. Regulated expression of foreign genes if! vivo after germ line transfer. J Clin Invest 1994; 94: 2421-2425.
9. Efrat S et al. Conditional transformation of a pancreatic β-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA 1995; 92: 3576-3580.
10. Shockett P et al. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci USA 1995; 92: 6522-6526.
11. Schultze et al. Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nat Biotechnol 1996; 14: 499-503.
12. Fishman GI, Kaplan ML, Buttrick P. Tetracycline-regulated cardiac gene expression in vivo. J Clin Invest 1994; 93: 1864-1868.
13. Paulus W et al. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 1996; 70: 62-67.
14. Liang X et al. Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy. Gene Therapy 1996; 3: 350-356.
15. Valcavi U. Tetracyclines. chemical aspects and some structure-activity relationships. In Grassi GG, Sabath LD (eds). New Trends in Antibiotics: Research and Therapy. Elsevier/North-Holland Biomedical Press: Amsterdam, 1981, pp 3-25.
16. Klien NC, Cunha BA. Tetracyclines. Med Clin North Am 1995; 79: 789-801.
17. Kistner A et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 10933-10938.
18. Akahane K, Pluznik DH. Interferon-gamma destabilizes interleukin-1 induced granulocyte-macrophage colony stimulating factor mRNA in murine vascular endothelial cells. Exp Hematol 1993; 21: 878-884.
19. Cunha BA, Garabedian-Ruffalo SM. Tetracyclines in urology. Curr Con Urol 1990; 36: 548-555.
20. Oliva B et al. Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob Agents Chemother 1992; 36: 913-919.
21. Gossen M, Bujard H. Anhydrotetracycline, a novel effector for tetracycline controlled gene expression systems in eukaryotic cells. Nucleic Acids Res 1993; 21: 4411-4412.
22. Clontech Product Protocol, 1996.
23. Alvarez-Vallina L, Agha-Mohammadi S, Russell S. Pharmacological control of antigen responsiveness m genetically modified T lymphocytes, (submitted for publication).
24. Agha-Mohammadi S, Hawkins RE. Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system. (submitted for publication).
25. Lederer T et al. Tetracycline analogs affecting binding to Tn10-encoded let represser trigger the same mechanism of induction. Biochemistry 1996; 35: 7439-7446.
26. Degenkolb J, Takahashi M, Ellestad GA, Hillen W. Structural requirements of tetracycline-tet repressor interaction, determination of equilibrium binding constants for tetracycline analogs with the tet repressor. Antimicrob Agents Chemother 1990; 35: 1591-1595.
27. Lambert HP, O'Grady F. Antibiotic and Chemotherapy, 6th edn. Churchill Livingstone: Edinburgh, 1992, pp 277-290.
28. Gabler WL, Smith J, Tsukuda N. Comparison of doxycycline and a chemically modified tetracycline inhibition of Leukocyte functions. Res Commun Chem Path Pharmaco 1992; 78: 151-160.
29. Cunha BA, Sibley C, Ristuccia A. Doxycycline. Ther Drug Momt 1982; 4: 115-135.
30. Sande MA, Mandell GL. Antimicrobial agents. In. Goodman LS, Gilman A eds. The Pharmacological Basis of Therapeutics, 7th edn. Macmillan: New York, 1985, p 1170.
31. Cunha BA, Comer JB, Jones M. The tetracyclines. Med Clin North Am 1982; 66: 293-302.
32. Houin G et al. The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man. Br J Clin Pharmac 1983; 16: 245-252.
33. Gossen M et al. Transcriptional activation of tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.